Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in the U.S. Virgin Islands: The Definitive Guide for Women and Families

If you are a woman in the U.S. Virgin Islands who has experienced complications following breast reconstruction, augmentation, or mastopexy, we understand that you may be facing one of the most frightening challenges of your life. Whether your surgery took place at a local facility like Schneider Regional Medical Center in St. Thomas or Governor Juan F. Luis Hospital in St. Croix—or if you traveled to the mainland U.S. for specialty care—the discovery that an implanted medical device may be failing is traumatic. At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we believe that the women of the U.S. Virgin Islands deserve the same level of sophisticated, aggressive legal representation as those in the largest mainland medical hubs. Managed by Ralph Manginello, a veteran trial attorney with twenty-seven years of continuous practice across federal and state courts, our firm provides the technical and regulatory command required to hold massive device manufacturers accountable.

The reality for many in the U.S. Virgin Islands is that surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds were often marketed to your surgeons as “safe” and “effective” shortcuts to a better aesthetic or reconstructive result. However, the United States Food and Drug Administration (FDA) has specifically stated that the safety and effectiveness of these products for breast surgery have never been formally determined. If you are experiencing pain, swelling, or have received a diagnosis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), our team is here to provide answers. You can reach us 24/7 at 1-888-ATTY-911 for a confidential, no-obligation consultation about your rights in the U.S. Virgin Islands.

Understanding the Devices Used in U.S. Virgin Islands Breast Procedures

For many patients in the U.S. Virgin Islands, the terminology used in surgical consent forms can be overwhelming. It is essential to understand the materials that may currently be in your body. Acellular Dermal Matrix is a biologic material, often human-cadaver-derived (like AlloDerm, FlexHD, or AlloMax) or porcine-derived (like Strattice), that is used as a “sling” to support a breast implant or tissue expander. Bioabsorbable scaffolds, such as GalaFLEX or Phasix, are synthetic products made of poly-4-hydroxybutyrate (P4HB) designed to be absorbed by the body over time.

While these products are widely used in the U.S. Virgin Islands for “internal bra” techniques and post-mastectomy reconstruction, for many women, they lead to a devastating “foreign body” response. Ralph Manginello and our legal team are currently investigating claims where these materials have caused chronic infections, reconstruction failure, and permanent disfigurement. We bring the same intensity to these cases that we apply to high-profile litigation like our current $10,000,000 lawsuit, Bermudez v. Pi Kappa Phi, where we represent victims against large, multi-defendant institutional entities. We understand that taking on a manufacturer like Becton Dickinson, Allergan, or Johnson & Johnson requires a firm with established federal litigation experience and the resources to see a case through to a verdict.

The FDA’s Regulatory Failure and the 510(k) “Shortcut”

The greatest misconception among patients in the U.S. Virgin Islands is that if a device is in an operating room, it must have been “approved” by the FDA. The truth is much more concerning. Most breast mesh and ADM products reached the market through the 510(k) clearance pathway (21 USC §360c). This is not a rigorous safety evaluation. Instead, it is a “substantial equivalence” finding where a manufacturer claims a new product is similar to a “predicate” device already on the market.

For women in the U.S. Virgin Islands, this has led to “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicate devices—a product never intended to reinforce breast tissue. Ralph Manginello often reminds clients that under the landmark Supreme Court case Medtronic v. Lohr (518 U.S. 470), the 510(k) process does not shield manufacturers from being sued for negligence. This is a critical distinction because while Class III devices with Premarket Approval (PMA) often enjoy “preemption” under Riegel v. Medtronic (552 U.S. 312), the 510(k)-cleared products used in the U.S. Virgin Islands—like FlexHD, AlloMax, and GalaFLEX—do not have that same level of immunity.

Our firm is deeply familiar with these regulatory nuances. Associate Attorney Lupe Peña, who is admitted to the United States District Court for the Southern District of Texas and is a key member of our litigation team, brings specialized knowledge of how insurance companies and manufacturers attempt to hide behind these federal labels. Lupe Peña also provides full client consultations in fluent Spanish, ensuring that the diverse population of the U.S. Virgin Islands has direct, language-concordant access to high-level legal strategy without the need for intermediaries. If you have questions about the 510(k) status of your specific device, contact us at 888-ATTY-911.

Recognizing Complications in the U.S. Virgin Islands Patient Population

If you live in St. Thomas, St. Croix, or St. John, you may have found it difficult to find specialists who can explicitly diagnose mesh-related or ADM-related injuries. Many complications present months or even years after the initial surgery. We represent women in the U.S. Virgin Islands who are facing a wide spectrum of injuries, including:

• Red Breast Syndrome (RBS): This is a non-infectious, sterile inflammatory response specific to ADM. Research indicates it is often caused by bacterial endotoxins (lipopolysaccharides) retained on the matrix even after sterilization. If you have persistent redness over your reconstruction that does not respond to antibiotics, your ADM may be the cause.
• Skin-Flap Necrosis: This involves the death of the breast tissue overlying the implant, often exacerbated by the tension or immunological response to a mesh or scaffold. This can lead to the “loss of the breast envelope” and total reconstruction failure.
• BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): This is a CD30-positive, ALK-negative T-cell lymphoma. If you have developed a late-onset seroma (fluid collection) or a mass around your implant 7 to 10 years after surgery, you must seek a biopsy.
• Bioabsorbable Scaffold Persistence: Products like GalaFLEX are supposed to resorb within 18 to 24 months. However, we have seen reports of these scaffolds remaining palpable and causing inflammation years later, failing to perform as marketed.

Ralph Manginello’s twenty-seven years of experience allows us to look at your medical records and see what general practitioners might miss. We understand the pathological markers—like T-cell receptor monoclonality or specific immunohistochemistry—that are the keys to a successful product liability claim. We handle every aspect of the case, from securing your operative reports to preserving your explanted device as evidence.

The Allergan BIOCELL MDL 2921 and the Path to Recovery

Many women in the U.S. Virgin Islands are currently wondering about the status of the Allergan BIOCELL recall. In July 2019, the FDA requested a global recall of BIOCELL textured implants because they were associated with a six-fold increase in BIA-ALCL risk. This litigation is currently centralized in the United States District Court for the District of New Jersey as MDL 2921.

Ralph Manginello and Lupe Peña are following this litigation closely, including the upcoming bellwether trials currently scheduled for October 19, 2026. For a woman in the U.S. Virgin Islands, navigating a federal Multidistrict Litigation (MDL) requires an attorney who understands the federal docket. Because Ralph Manginello is admitted to the Southern District of Texas and has practiced for nearly three decades, we have the jurisdictional fluency required to file and prosecute cases in the appropriate federal venues. We also draw on our social proof, such as our 4.9-star rating on Birdeye across hundreds of reviews and Ralph Manginello’s Avvo “Excellent” 8.2 rating, to provide the reassurance that you are working with a firm that is both respected by its peers and trusted by its clients.

Why U.S. Virgin Islands Residents Choose Attorney911

The Manginello Law Firm, PLLC is not a “settlement mill.” We are a trial-ready firm rooted in a commitment to service. Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a recognition reserved for those who exceed seventy-five hours of pro bono service annually. We bring that same ethic to our U.S. Virgin Islands clients. We know that many residents of the U.S. Virgin Islands feel “out of sight, out of mind” for mainland corporations. We refuse to let that happen.

We also offer a significant advantage through Lupe Peña’s background. With experience in insurance defense, Lupe knows the “playbook” the manufacturers will use to try and deny your claim. They will argue that your complications were caused by your own body’s “natural rejection” or by the surgeon’s technique, rather than their defective product. We know how to counter these arguments using the Daubert evidentiary framework (509 U.S. 579) and expert testimony.

Furthermore, we are deeply aware of the whistleblower record of Dr. Hooman Noorchashm, the former Becton Dickinson Medical Director who alleged that safety concerns regarding GalaFLEX were suppressed. When we represent a woman in the U.S. Virgin Islands, we use every piece of investigative data—from MAUDE database reports to internal manufacturer memos—to build a case that is competitor-proof.

Frequently Asked Questions for U.S. Virgin Islands Patients

Is surgical mesh or ADM approved by the FDA for breast surgery?
No. As of our most recent review of FDA safety communications, no surgical mesh or ADM product has been specifically “approved” for use in breast reconstruction or augmentation. They are “cleared” for general soft-tissue reinforcement, but the FDA warned in its November 9, 2023, letter that their safety in breast tissue has not been determined.

What is the statute of limitations in the U.S. Virgin Islands for a mesh lawsuit?
In the U.S. Virgin Islands, the statute of limitations for personal injury and product liability generally requires you to file your claim within two years of the date you discovered, or reasonably should have discovered, your injury. Because these injuries often develop slowly, the “discovery rule” is critical. Waiting can permanently bar your right to recovery, so contact Ralph Manginello at 888-288-9911 as soon as you suspect a problem.

How do I find out which brand was used in my surgery at a U.S. Virgin Islands hospital?
You have a legal right to your medical records. You must request your “Operative Report” and the “Implant Log.” These documents contain the Unique Device Identifier (UDI) stickers and lot numbers for every product used. If the hospital is uncooperative, our firm can facilitate this process for you.

Can I sue if I have not been diagnosed with cancer?
Yes. While BIA-ALCL is a major focus, the majority of our cases involve systemic injuries, chronic pain, severe infections, Red Breast Syndrome, and reconstruction failure. These “non-cancer” injuries are life-altering and are legitimate grounds for a lawsuit in the U.S. Virgin Islands.

What if I didn’t have my surgery in the U.S. Virgin Islands?
Many U.S. Virgin Islands residents travel to Florida or Puerto Rico for surgery. We focus on where the manufacturer is located and where the harm was sustained. Ralph Manginello’s federal court admission allows us to handle these multi-state jurisdictional questions with ease.

Does it cost anything to start my case?
No. At The Manginello Law Firm, PLLC, we work on a contingency fee basis. This means we advance all the costs of litigation, including hiring scientific experts and filing fees. You pay us nothing unless we recover money for you.

Your Path Forward in the U.S. Virgin Islands

For a woman in the U.S. Virgin Islands, the loss of her breast reconstruction or the discovery of a device-related cancer is a violation of the trust she placed in the medical system. We are here to restore the balance of power. Whether you are in Charlotte Amalie, Christiansted, Frederiksted, or Cruz Bay, Attorney911 is your advocate.

We provide a Technical Authority that generalist personal injury firms cannot match. When you speak with us, we won’t give you a generic marketing pitch. Ralph Manginello will discuss the specific 21 CFR §803 reporting requirements or the P4HB hydrolysis kinetics of your GalaFLEX scaffold. We speak the language of the courtroom and the laboratory.

You are not alone. There is a community of survivors in the U.S. Virgin Islands, and there is a law firm that knows your name and your story. We invite you to listen to our “Attorney 911” podcast on Apple Podcasts or Spotify to hear Ralph Manginello explain the law in plain English, or visit our YouTube channel @Manginellolawfirm to see our commitment to transparency.

When you are ready to take the next step, call 1-888-ATTY-911. We are available 24/7 to take your call. Hablamos español. Lupe Peña and Ralph Manginello are ready to fight for you. There is no fee unless we win, and our first consultation is always free. Let us help you secure the justice and the compensation you need to heal and move forward with your life in the U.S. Virgin Islands.

Legal and Regulatory Context for U.S. Virgin Islands Residents

We emphasize that every case is unique. Your ability to recover compensation depends on the specific brand of mesh or ADM used, the date of your surgery, the nature of your complications, and the statute of limitations. While we have achieved significant results, such as Ralph Manginello’s and Lupe Peña’s current representation in the high-profile Bermudez institutional liability case, past results do not guarantee future outcomes. We are dedicated to providing the most rigorous legal analysis for our U.S. Virgin Islands clients, ensuring that every 21 CFR §807 Subpart E clearance and 21 CFR §803 Medical Device Report is scrutinized. Our firm holds an A+ standing with the Better Business Bureau (ID 0915-58003169) and is a member of the Pasadena Chamber of Commerce, symbols of our commitment to professional excellence and community service. Don’t let the distance between the U.S. Virgin Islands and the mainland stop you from seeking the justice you deserve. Call 1-888-288-9911 today.